OPKO Health Reports First Quarter 2024 Business Highlights and Financial Results Conference call begins at 4:30 p.m. Eastern time today MIAMI, May 07, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three months ended March 31, 2024. First quarter business highlights include the following: Entered into an agreement with Labcorp to sell select assets of BioReference Health. The transaction includes the sale of BioReference Health’s laboratory testing businesses focused on clinical diagnostics and women’s health, excludi...
A director at Macerich Co bought 140,000 shares at 14.263USD and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly...
OPKO Health to Report First Quarter 2024 Financial Results on May 7, 2024 MIAMI, May 03, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended March 31, 2024 after the close of the U.S. financial markets on Tuesday, May 7, 2024. OPKO’s senior management will provide a business update and discuss results as well as financial guidance during a conference call and live audio webcast on May 7th beginning at 4:30 p.m. Eastern time. CONFERENCE CALL & WEBCAST INFORMATION OPKO encourages participants to pre-register f...
SuRo Capital Corp. to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024 NEW YORK, May 02, 2024 (GLOBE NEWSWIRE) -- (“SuRo Capital”) (Nasdaq: ) today announced that it will report its financial results for the quarter ended March 31, 2024 after the close of the U.S. market on Wednesday, May 8, 2024. Management will hold a conference call and webcast for investors at 2:00 p.m. PT (5:00 p.m. ET). The conference call access number for U.S. participants is 866-580-3963, and the conference call access number for participants outside the U.S. is . The conference ID number ...
Macerich Reports First Quarter 2024 Results SANTA MONICA, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- The Macerich Company (NYSE: MAC) has released its First Quarter 2024 Earnings Results and Supplemental Information by posting it to the Investor Relations section of its website at . As previously announced, management will hold a conference call at 10:00 a.m. Pacific Time (1:00 p.m. Eastern Time) today, Tuesday, April 30, 2024, to discuss quarterly results. Participants who wish to join the conference by telephone must register at the dial-in registration link below to receive the dial-i...
Macerich Declares the Quarterly Dividend on Its Common Shares SANTA MONICA, Calif., April 26, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of the Macerich Company (NYSE: MAC) declared a quarterly cash dividend of $.17 per share of common stock. The dividend is payable on June 3, 2024, to stockholders of record at the close of business on May 20, 2024. About Macerich Macerich is a fully integrated, self-managed, self-administered real estate investment trust (REIT). As a leading owner, operator, and developer of high-quality retail real estate in densely populated and attractive U...
Macerich Celebrates Earth Month With ‘You Pledge We Plant’ Campaign, Industry Recognition Campaign To Plant 100,000+ Trees to Support Reforestation, Urban Forestry Retail REIT Named Green Lease Leader, Honored Among ‘America’s Most Responsible Companies’ SANTA MONICA, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Macerich (NYSE: ), one of the nation’s leading owners, operators and developers of high-quality retail real estate in top markets, is celebrating Earth Month with its “You Pledge We Plant” campaign to plant more than 100,000 trees across the country. In partnership with , Maceric...
SuRo Capital Corp. First Quarter 2024 Preliminary Investment Portfolio Update Net Asset Value Anticipated to be $6.90 to $7.40 Per Share NEW YORK, April 16, 2024 (GLOBE NEWSWIRE) -- (“SuRo Capital”, the “Company”, “we”, “us”, and “our”) (Nasdaq: ) today provided the following preliminary update on its investment portfolio for the first quarter ended March 31, 2024. “We remain incredibly enthusiastic about both our investment pipeline and our current portfolio as the IPO market strengthens and new opportunities at compelling valuations continue to come to light. We are now executing on...
Macerich Schedules First Quarter 2024 Earnings Release and Conference Call SANTA MONICA, Calif., April 08, 2024 (GLOBE NEWSWIRE) -- WHAT: Macerich (NYSE: MAC) Schedules First Quarter 2024 Earnings Release and Conference Call WHEN: Earnings Results will be released before market open on Tuesday, April 30, 2024. Management will hold a conference call at 10:00 am Pacific Time (1:00 pm Eastern Time) on that same day to discuss quarterly results. WHERE: Participants who wish to join the conference by telephone must register at the dial-in registration link below to receive the dial-in numb...
SuRo Capital Corp. Announces Expiration and Final Results of Tender Offer Modified Dutch Auction Tender Offer to Repurchase 2 Million Shares at $4.70 Per Share NEW YORK, April 03, 2024 (GLOBE NEWSWIRE) -- (“SuRo Capital” or the “Company”) (Nasdaq: ) today announced its final results from its modified “Dutch Auction” tender offer (the “Tender Offer”). The Company’s Tender Offer expired at 5:00 P.M., Eastern Time, on April 1, 2024. The Tender Offer was made pursuant to an Offer to Purchase dated February 20, 2024 and the related Letter of Transmittal, by which the Company offered to purc...
SuRo Capital Corp. Tender Offer Expiring on April 1, 2024 at 5:00 P.M., Eastern Time Modified Dutch Auction Tender Offer to Repurchase up to 2 Million Shares at a Price per Share Between $4.00 and $5.00 NEW YORK, March 22, 2024 (GLOBE NEWSWIRE) -- (“SuRo Capital”, the “Company”, “we”, “us”, and “our”) (Nasdaq: ) today reminded its stockholders its modified “Dutch Auction” tender offer (the “Tender Offer”), which commenced on February 20, 2024, remains scheduled to expire at 5:00 P.M., Eastern Time, on April 1, 2024. The Company launched the Tender Offer to purchase up to 2,000,000 shar...
A director at Opko Health Inc bought 500,000 shares at 0.874USD and the significance rating of the trade was 60/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...
SuRo Capital Corp. Reports Fourth Quarter and Fiscal Year 2023 Financial Results Net Asset Value of $7.99 Per Share as of December 31, 2023 Modified Dutch Auction Tender Offer to Repurchase Up To 2 Million Shares Commenced on February 20 NEW YORK, March 13, 2024 (GLOBE NEWSWIRE) -- (“SuRo Capital”, the “Company”, “we”, “us”, and “our”) (Nasdaq: ) today announced its financial results for the fourth quarter and fiscal year ended December 31, 2023. Net assets totaled approximately $203.4 million, or $7.99 per share, at December 31, 2023, as compare...
Macerich Marks 30 Years as Public Company, Rings Closing Bell at New York Stock Exchange New Company President & CEO Jack Hsieh Joined by Senior Executives for Celebratory Milestone SANTA MONICA, Calif., March 12, 2024 (GLOBE NEWSWIRE) -- Macerich (NYSE: ), one of the nation’s leading owners, operators and developers of high-quality retail and mixed-use properties in top markets, today marked its 30th anniversary as a public company by ringing the closing bell at the New York Stock Exchange. Jack Hsieh, who took the reins as Macerich President and CEO on March 1, 2024, was joined by a ...
SuRo Capital Corp. to Report Fourth Quarter and Fiscal Year 2023 Financial Results on Wednesday, March 13, 2024 NEW YORK, March 06, 2024 (GLOBE NEWSWIRE) -- (“SuRo Capital”) (Nasdaq: ) today announced that it will report its financial results for the quarter and fiscal year ended December 31, 2023 after the close of the U.S. market on Wednesday, March 13, 2024. Management will hold a conference call and webcast for investors at 2:00 p.m. PT (5:00 p.m. ET). The conference call access number for U.S. participants is 866-580-3963, and the conference call access number for participants outs...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.